Pfizer $PFE is a mess. The company has a slowdown ahead and the latest report is a disappointment. $PFE, Pfizer, Inc. / H1 With selling momentum sending the stock to new lows throughout February, $30 might mark the bottom.Avoid PFE stock until shares fell another 10%.